ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY
Nonsteroidal anti-inflammatory drugs (NSAIDs) are able to effectively control the major symptoms of rheumatic diseases and widely used in real clinical practice. However, they may cause serious gastrointestinal (GI) and cardiovascular (CV) events. The prevention of these events is based on the estim...
Saved in:
| Main Authors: | A. E. Karateev, T. V. Popkova, D. S. Novikova, E. L. Nasonov, G. A. Togizbaev, N. A. Martusevich, A. A. Aroyan, M. Z. Rizamukhamedova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2014-12-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
by: Jacky van Schoor
Published: (2014-07-01) -
How effective is the average therapeutic dose of a nonsteroidal anti-inflammatory drug in osteoarthritis?
by: A. E. Karateev
Published: (2019-03-01) -
Risk Factors and Prevention of Upper Gastrointestinal Complications Associated with Nonsteroidal Anti-Inflammatory Drugs
by: N. V. Bakulina, et al.
Published: (2025-02-01) -
NEW DATA ON THE SAFETY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: THE CONCEPT OF THE HIGH CLASS-SPECIFIC CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS IS OUTDATED
by: A. E. Karateev, et al.
Published: (2017-04-01) -
USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
by: Yu. A. Olyunin
Published: (2017-07-01)